X @The Wall Street Journal
The Wall Street Journal·2026-03-02 07:03
The drugmaker said the results provide convincing evidence that fenebrutinib can become the first high-efficacy oral treatment for relapsing and primary progressive multiple sclerosis. https://t.co/oo2aUPh8rJ ...